ArticleJACC. Advances2026
Modifiable Risk Factors for Atrial Fibrillation/Flutter in the Association of Southeast Asian Nations: Global Burden of Disease 2021.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtrial fibrillation (AF) and atrial flutter (AFL) is increasingly contributing to cardiovascular mortality in Southeast Asia; however, region-specific data on modifiable risk factors remain limited.
objectivesThis study aimed to assess the burden of AF/AFL attributable to modifiable risk factors across the Association of Southeast Asian Nations (ASEAN) using Global Burden of Disease 2021 data.
methodsWe analyzed the Global Burden of Disease 2021 data for all 10 ASEAN nations (1990-2021). The burden of AF/AFL attributable to metabolic, behavioral, and environmental risk factors was assessed, stratified by sex. The outcomes included age-standardized mortality rates (ASMRs), disability-adjusted life years (DALYs), and years lived with disability. Forecasts to 2035 were generated using validated time-series models.
resultsBetween 1990 and 2021, the ASMRs for AF/AFL attributable to modifiable risk factors varied markedly across ASEAN countries. Metabolic risks rose from 1.30 (0.48-2.14) in 1990 to 1.78 (0.98-2.87) in 2021, followed by behavioral (0.42-0.45) and environmental (0.08-0.11) risks. Vietnam had the highest metabolic-attributable ASMR at 2.06 in 2021, whereas Singapore's declined to 0.31 in the same year. Metabolic DALYs peaked in Indonesia at 52.29 in 2021 and were lowest in Singapore at 12.35. Males consistently showed higher ASMRs and DALYs than females, a gap projected to persist through 2035, reflecting persistent metabolic dominance and uneven progress across ASEAN.
conclusionsMetabolic risk factors remain the dominant contributors to AF/AFL mortality across ASEAN, with widening disparities across countries and sexes. Strengthening targeted prevention strategies is essential to reduce cardiovascular risk and achieve equitable progress by 2035.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.